A novel serum metabolomics-based diagnostic approach to pancreatic cancer. - Wikidata - awgldk - TriplyDB

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

http://www.wikidata.org/entity/Q34642793

about

Cancer Metabolomics and the Human Metabolome Database Translational metabolomics in cancer research Head mass in chronic pancreatitis: Inflammatory or malignant Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.1HNMR-based metabolomic profile of rats with experimental acute pancreatitis.MALDI-mass spectrometric imaging for the investigation of metabolites in Medicago truncatula root nodules Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Metabolomics for biomarker discovery in gastroenterological cancer.Optimization and comparison of multiple MALDI matrix application methods for small molecule mass spectrometric imaging.Plasma metabolite biomarkers for the detection of pancreatic cancer A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients Biomarker Discovery and Translation in Metabolomics.Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer A review of applications of metabolomics in cancer.Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics.Plasma-free amino acid profiles are predictors of cancer and diabetes development.Review article: breath analysis in inflammatory bowel diseases.Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.Metabolomics in pancreatic cancer biomarkers research.Early detection of pancreatic cancer: Where are we now and where are we going?A Systematic Strategy for Screening and Application of Specific Biomarkers in Hepatotoxicity Using Metabolomics Combined With ROC Curves and SVMs.Simultaneous Quantification of Serum Multi-Phospholipids as Potential Biomarkers for Differentiating Different Pathophysiological states of lung, stomach, intestine, and pancreas Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis.Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis.Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.High-throughput and high-sensitivity quantitative analysis of serum unsaturated fatty acids by chip-based nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry: early stage diagnostic biomarkers of pancreatic cancer Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.Metabolome analysis for pancreatic cancer risk in nested case-control study: Japan Public Health Center-based prospective Study.Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.

P2860

Q26767342-78CB91D0-C930-4F3F-8EFC-D013BEE0FB13 Q26998663-261269A3-02D5-4454-8EAD-0BB71F589697 Q27011806-43F6A714-710C-4F04-8B4D-0C62EB6F8C6F Q27022231-B0E91B92-D8DA-4CDA-AE80-7B3DBF494B39 Q31126519-92E6059E-DABB-4FCF-8B93-7CC91DAA3D89 Q33635144-3F078E8D-552F-4A24-A645-066B08474BD2 Q33710031-37F26DB2-307A-48E7-8D23-CEB9871ABB35 Q33909240-EDF5B2DF-C61F-4B1B-BAEB-2B7D747867F7 Q34082136-92E2A164-86F7-48E2-BB2C-EB6ED0EDD6B6 Q34315320-52CE0811-27B8-407C-A6BB-163D75EF8782 Q34318206-43FE8698-C4EC-480C-AA92-3079047F34AA Q34379803-B978ADD3-E68D-483F-A021-9E1724C9FCB0 Q35072866-98610DD7-C823-470C-A0DF-EE3F4F71DE0D Q35680475-71928226-8DF7-475F-8EEB-A1CC6A0E06CD Q36048320-79C86D1E-88C9-498A-A6DC-4D5573C0C19E Q36245590-B4C866A0-A9E7-47D2-A6F8-9F3198CBCBBF Q36845593-2586AB10-2ED3-4DDB-B033-47BE67231CD7 Q37022332-6266C27F-80A2-485B-9AF0-65368AC2E5A7 Q37399898-6CFDFE1E-14B1-4724-AD5B-D534B36E1C93 Q37512830-2E35ACEF-E8D0-4DCF-893D-19DAD816670C Q37728545-EB346691-BE37-442D-A7B1-5DC42BF08891 Q37733470-98AD944E-FF10-4BDE-9F1D-75E36E90CC27 Q37737774-5520B9AC-5DF8-4CFB-B34F-E745B3ED4422 Q38293574-411764D0-C15D-47D3-AE34-F9918AF46CAE Q38965713-E30854E0-D89B-42F6-ABCA-2C5C5DC5AE18 Q38997162-A4F07495-C469-4C72-80AF-E3BE1FBED4AC Q39152619-00B6EDA2-0B4C-4D77-89D1-F479D37F06D1 Q40092878-40977A97-DC18-4C79-AABB-1C385E8A1819 Q41440976-1CF74712-DA75-46B0-8BE2-D49433BA3210 Q42154484-0800F6B6-4C6D-49D0-9C0E-3A9F2F9FD3A9 Q43104456-3B101574-C7CA-48AC-BF9F-352C55B4A491 Q43508439-87D95BF2-EF9B-4089-9BF4-CB997380A4BB Q46860779-0164D8F4-8F65-4182-BF1C-EA9A94A33E93 Q47179835-11238C66-070E-488A-8F9D-EE2F1CC73602 Q48308467-FAE62141-B5B7-4377-B945-1E0CC0D53AC1 Q49701167-D544FD80-EFC8-445D-8058-28E04DE593AD Q51521398-32273AAE-29F6-4A9E-B378-344DB7D6068D Q52595056-C1692A60-C325-4BAA-81F6-24139A1B6007 Q52633517-2FA5B71F-51E1-4BA6-BEA4-EF9B6D3536E1 Q52998486-F3829678-AAA1-4155-B0B6-64060F026774

P2860

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

http://www.wikidata.org/entity/Q34642793

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@ast

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@en

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@nl

type

label

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@ast

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@en

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@nl

prefLabel

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@ast

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@en

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

@nl

P1433

Q34642793-A87FC207-70EA-42EF-A96C-D1214106C4BD

P1476

Q34642793-2FE986EA-F368-4A87-B1A8-4A656D62B2CC

P2093

Q34642793-1ACEEF15-5480-4AB4-9FA4-6C010986911A

Q34642793-1FD64D54-F42E-4546-87AE-1D743F4AD772

Q34642793-41A36D02-90F2-4F31-9D0E-F5DF44B86404

Q34642793-43631039-E5FD-4BF2-951C-7DAFA486F093

Q34642793-69A43537-A42B-4568-8A2F-38135FE0A8C2

Q34642793-974A185D-716C-4F03-9FF0-1634F9A14176

Q34642793-A25B0ECD-3AF7-4316-BD00-D37886D0A2C7

Q34642793-A55FCE73-EB9C-4AC2-8DCA-CF7E78E3BE99

Q34642793-B632501E-8631-4598-8FF2-2CEC3F8D4EE1

Q34642793-B88088AC-817D-4EFB-A43B-BFE31796F570

P304

Q34642793-FEF38C10-F7D7-4567-831E-89A936DFFBDB

P31

Q34642793-3B0F48C7-66EB-4E7D-852E-6D7C0B899D5F

P356

Q34642793-0E97F1EA-23FE-4DAB-A749-D4AA696C30A8

P433

Q34642793-04E58310-500D-4E85-A7CE-7F7076FEA7F6

P478

Q34642793-29346645-EB06-4D87-873D-BA3A703498E6

P50

Q34642793-879091BE-CB22-4972-99EC-4493AE7713D3

Q34642793-CD9E25FC-2AEF-4283-A83C-975AE17CE9F7

P577

Q34642793-3886A70F-1A35-4302-B421-708B0A8BFC18

P698

Q34642793-F43247A0-CF76-4072-8315-B52286B8DBB7

P356

1055-9965.EPI-12-1033

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

A novel serum metabolomics-based diagnostic approach to pancreatic cancer

@en

P2093

Atsuki Ikeda

http://www.w3.org/2001/XMLSchema#string

Atsuki Matsubara

http://www.w3.org/2001/XMLSchema#string

Aya Sakai

http://www.w3.org/2001/XMLSchema#string

Hidetaka Tsumura

http://www.w3.org/2001/XMLSchema#string

Hironobu Minami

http://www.w3.org/2001/XMLSchema#string

Hogara Nishisaki

http://www.w3.org/2001/XMLSchema#string

Masahiro Tsuda

http://www.w3.org/2001/XMLSchema#string

Masaru Yoshida

http://www.w3.org/2001/XMLSchema#string

Nobuhide Hayashi

http://www.w3.org/2001/XMLSchema#string

Seiji Kawano

http://www.w3.org/2001/XMLSchema#string

P304

571-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-12-1033

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Takashi Kobayashi

Yutaka Fujiwara

P577

2013-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23542803

http://www.w3.org/2001/XMLSchema#string